Cheng, Wanying
Maimaiti, Xiayida
Zhao, Jiubo
Funding for this research was provided by:
the National Natural Science Foundation of China (72174082 & 82373695)
the Natural Science Foundation of Guangdong Province (2023A1515011825)
the Guangdong-Hong Kong Joint Laboratory for Psychiatric Disorders (2023B1212120004)
Article History
Received: 6 November 2024
Accepted: 4 December 2025
First Online: 26 December 2025
Competing interests
: The authors declare no competing interests.
: Ethical approval for this study was obtained from the Ethics Committee of Southern Medical University (Approval Nan Yi Lun Shen 2021 No.011) on July 14, 2021. All research procedures were performed in accordance with the ethical standards of the Declaration of Helsinki. The approved protocol encompassed the recruitment of outpatients with depression, the delivery of the personalized psychological intervention and treatment-as-usual, and the collection and analysis of all outcome measures.
: Written informed consent was obtained from all participants and, for participants under the age of 18, from their parents or legal guardians. The consent process was conducted by the principal investigator and trained research coordinators prior to any study procedures (between August 2023 and February 2024). Participants and their guardians were comprehensively informed about the study’s aims, procedures, potential risks and benefits, confidentiality safeguards, and their right to withdraw without penalty. The consent covered participation in the study, the use of their anonymized data for research purposes, and the publication of aggregated findings.